期刊文献+

中西医结合治疗咳嗽变异性哮喘疗效观察 被引量:7

下载PDF
导出
摘要 目的:观察中西医结合治疗咳嗽变异性哮喘(CVA)的临床疗效。方法:75例分为对照组37例和治疗组38例,两组均用舒利迭(50/250)1吸,12h1次,治疗组联合自血穴位注射,疗程8周。结果:中医证候疗效总有效率对照组73.0%,治疗组92.1%,两组比较差异有统计学意义(P<0.05)。控显率对照组59.5%、治疗组81.6%,两组比较差异有统计学意义(P<0.05)。中医单症状疗效治疗组咳嗽、胸闷疗效优于对照组(P<0.05),治疗中未出现严重不良反应。结论:自血穴位注射疗法能够改善临床症状,且无明显不良反应。 Objective : To observe the clinical therapeutic effect of combination of TCM and western medicine in treating c, ough variant asthma ( CVA ) .Method: 75 patients of CVA were divided into 2 groups, 37 cases in the control group and 38 cases in the study group. Both groups were treated with salmeterol and fluticasone propionate inhalation ( 50/250 ) .The study group were treated with self-blood acupoint injection therapy in addition. The treatment lasted for 8 weeks. Result: For TCM syndrome curative effect comparison, the total effective rate of the control group was 73% while that of the treatment group was 92.1%.There was significant difference between the two groups ( P〈0.05 ) . The control rate of the treatment group and the control group was 59.5% and 81.6% respectively. The difference was significant between the two groups ( P〈 0.05 ) .Compared the cough and chest tightness symptom, the improvement of the treatment group was superior to that of the control group (P〈0.05) . There was no serious adverse reactions observed in all the patients during the treatment. Conclusion: Self blood acupoint injection therapy couht effectively improve the clinical symptoms of patients with CVA without obvious adverse reaction.
出处 《实用中医药杂志》 2015年第4期294-295,共2页 Journal of Practical Traditional Chinese Medicine
基金 广东省佛山市医学类科技攻关项目(课题编号:201208147) 广东省佛山市科技发展专项资金项目(2012AA100662)
关键词 咳嗽变异性哮喘 西药 自血穴位注射 cough variant asthma western medicine self blood acupoint injection
  • 相关文献

参考文献3

二级参考文献9

  • 1Romagnani S. Regulation and deregulation of human IgE synthesis. [J] ImmunolToday, 1990,11(9 Sep) :316 - 321.
  • 2Humbert M, Durham S R, Ying S, et al. IL -4 and IL -5 mRNA and protein in bronchial biopsies with atopic and nonatiopic asthma: evidence against“intrinsic” asthma being a distinct immunopathologic entity[J]. Am J Respic Crit Care Med, 1996,153(5) :1503 - 1509.
  • 3Foster P S, Hogan S P, Ramsay A J, et al. Interleukin -5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma [J].J Exp Med, 1997,185(12):2143 -2156.
  • 4Humbert M, Corrigan C J, Kimmitt P, et al. Relationship between IL- 4 and IL- 5 mRNA expression and disease severity in atopic asthma [J]. Am J Respic Crit Care Med,1997,156(3):704 - 708.
  • 5Shi H, Xiao C, Zhong D, et al. Effect of inhaled IL -5 on airway hyperreaction and eosinophilia in asthmatics [J]. Am J Respic Crit Care Med,1998,157(1):204 -209.
  • 6Sanderson C J. Interleukin -5, eosimophils, and disease[J]. Blood, 1992, 79(12) :3101 -3109.
  • 7Foster P S, Hogan S P, Ramsay A J, et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model[J].J Exp Med, 1996,183(1):195 - 201.
  • 8Jean S. Marshall, Irene Leal -Berumen, Laurie Nielsen, et al. Interleukin (IL) -10 Inhibits Long- Term IL-6 Production but Not Preformed Mediator Release from Rat Peritoneal Mast Cells[J]. J Clin Invest,1996,97(4):1122 -1128 .
  • 9支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2007

共引文献1434

同被引文献56

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部